InsidersTradesSigma
Follow the 安必平 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 安必平 has published 7 insider filings. Market capitalisation: €1.7bn. The latest transaction was disclosed on 27 April 2026 (Sale). Among the most active insiders: 朱俊轩. Every trade is free.
7
Insider Decl.
n/a
Thresholds
€4,991
4 ops.
Buy Volume
€18,593
3 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,011 of 29,062 companies
36.7
score / 100
Value35
Quality39
FCF yld0.9%
Earn yld-2.6%
EV/EBITDA·
ROE-3.4%
Gross mgn64%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 April 2026
Declarations7 total
2,700 sharesA股XSHGSSE:173000006638916540
7 of 7 declarations
About 安必平
安必平 is a company operating in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative pharmaceutical products.